Ciampolillo F, Tung D E, Cameron J S
Department of Biological Sciences, Wellesley College, Massachusetts.
J Pharmacol Exp Ther. 1992 Jan;260(1):254-60.
Hyperpolarizing vasodilators that specifically activate ATP-sensitive K+ currents (IK(ATP] in smooth muscle have been suggested as promising antihypertensive (if potentially arrhythmogenic and/or hyperglycemic) therapy. To date, however, the effects of agents presumed to influence these channels have not been characterized in hypertrophied cardiac muscle secondary to chronic hypertension. We used standard intracellular and patch clamp, single-channel recording techniques to study the effects of diazoxide, a presumed activator, as well as the sulfonylurea glyburide on IK(ATP) in cardiac muscle from control (WKY) and spontaneously hypertensive rats (SHR). Intracellular recordings were obtained from isolated left ventricles at 37 degrees C; unitary currents were recorded in excised, inside-out membrane patches with symmetrical transmembrane K+ at 21-23 degrees C. Diazoxide (5-100 microM) caused a decrease in action potential duration in both WKY and SHR ventricles. Glyburide (5-25 microM) produced dramatic dose-dependent increases in action potential duration approaching 100% in both groups. Action potential amplitude and resting membrane potential were unaffected by either agent. Before drug administration, unitary currents in hypertrophied myocytes exhibited a greater open state probability upon depolarization than those from control myocytes, although conductance, mean single-channel open time, and the number of channels per patch were not significantly different. Under patch clamp, both diazoxide (25 and 100 microM) and glyburide (50 microM) decreased IK(ATP) activity in cells from WKY and SHR in the absence of ATP. In both groups, the response reflected an overall decrease in open state probability. These data indicate that although IK(ATP) characteristics are altered in hypertension and myocardial hypertrophy, the effects of agents specific to this current are not significantly different in cells from SHR relative to control. On the other hand, the effects of diazoxide may be linked to temperature or to the metabolic state of the cell.
特异性激活平滑肌中ATP敏感性钾电流(IK(ATP))的超极化血管扩张剂已被认为是一种有前景的抗高血压治疗方法(尽管可能有致心律失常和/或高血糖的风险)。然而,迄今为止,在继发于慢性高血压的肥厚心肌中,假定影响这些通道的药物的作用尚未得到明确。我们使用标准的细胞内和膜片钳单通道记录技术,研究了假定的激活剂二氮嗪以及磺脲类药物格列本脲对正常血压(WKY)大鼠和自发性高血压大鼠(SHR)心肌中IK(ATP)的影响。细胞内记录是在37℃下从分离的左心室获得的;在21 - 23℃下,在切除的内向外膜片中,用对称的跨膜钾记录单通道电流。二氮嗪(5 - 100微摩尔)使WKY和SHR心室的动作电位时程缩短。格列本脲(5 - 25微摩尔)使两组的动作电位时程显著剂量依赖性增加,接近100%。两种药物均未影响动作电位幅度和静息膜电位。在给药前,肥厚心肌细胞中的单通道电流在去极化时表现出比正常心肌细胞更高的开放概率,尽管电导、平均单通道开放时间和每个膜片的通道数量没有显著差异。在膜片钳实验中,在无ATP的情况下,二氮嗪(25和100微摩尔)和格列本脲(50微摩尔)均降低了WKY和SHR细胞中的IK(ATP)活性。在两组中,这种反应反映了开放概率的总体降低。这些数据表明,尽管在高血压和心肌肥厚中IK(ATP)特性发生了改变,但相对于正常对照,特异性作用于该电流的药物在SHR细胞中的作用并无显著差异。另一方面,二氮嗪的作用可能与温度或细胞的代谢状态有关。